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Abstract 
In this study, we purified C-terminal propeptide of type I collagen (PICP) from the conditioned medium of osteoblastic MC3T3-E1 
cells by chromatographic and Agarose gel extraction procedures. PICP was confirmed to be present in bone by Western blotting using a 
specific antibody, and was proved to be synthesized by osteoblasts with metabolic labeling. PICP promoted cell-attachment of
osteoblastic MC3T3-E1 cells. We conclude that PICP is synthesized by osteoblasts and stored in bone, and that it plays a role in the 
maintenance of bone cells on bone matrix. 
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1. Introduction 
Amino-terminal and carboxy-terminal propeptides are 
non-collagenous segments of fibril-forming collagens 
(types I, II and III). These propeptides play a role in the 
maintenance of the solubility of secreted procollagen 
molecules prior to the forming insoluble polymers [1]. 
They are released by file specific N -and  C-terminal 
propeptidases [2]. For final fibril-forming collagen, the 
removal of propeptides i  essential for fibrillogenesis [3]. 
These propeptides were considered to disappear from 
the extracellular site soon after they are released from 
procollagen. Recently C propeptides of type II collagen 
were found in cartilage, especially in the hypertrophic zone 
of growth plates [4,5]. Furthermore, N-terminal propeptide 
of type I collagen was recognized in bone [6,7]. These 
findings support the conjecture that C-terminal propeptide 
of type I collagen (PICP) is present in bone. However, 
there is no report confirming this hypothesis. 
In this study, we found that PICP was present in bone, 
and osteoblastic ells synthesize it. Furthermore, we puri- 
fied PICP from conditioned medium of osteoblastic 
MC3T3-E1 cells for the first time, and found that PICP 
promoted cell-attachment of osteoblasts. These findings 
indicate that PICP is one constituent of bone, and might 
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play a role in the maintenance of osteoblasts or osteocytes 
on bone. 
2. Materials and methods 
2.1. Osteoblastic ell culture 
Osteoblastic MC3T3-E1 cells were a kind gift from 
Drs. H. Kodama and Y. Amagai [8]. They have been 
maintained in our laboratory, and were confirmed to pro- 
duce bone-like nodules at approx. 14 days after confluency 
without /3-glycerophosphate [9,10]. The cells were cul- 
tured in a-MEM medium with 10% fetal calf serum at 
37°C in a fully humidified atmosphere of 5% CO 2. Cells 
were fed every two days. 
2.2. Purification of C-terminal propeptide of type I colla- 
gen (PICP) from conditioned medium 
Conditioned media (approx. 2 litres) were harvested 
from the cell cultures that formed mineralized nodules. 
They were concentrated by ultrafiltration (YM-10, Ami- 
con, Japan) and loaded on a Concanavalin A (Con A) 
Sepharose column (Pharmacia, Japan, 1.5 × 20 cm) equili- 
brated with 0.5 M NaC1/20 mM Tris (pH 7.4). After 
elution with 120 ml of the same buffer, the bound fraction 
was eluted by the above buffer containing 0.2 M a-methyl 
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mannoside. This fraction was further separated by a 
Sephacryl S-200 column (2 X 100 cm) eluted with 4 M 
urea/0.15 M NaC1/50 mM Tris (pH 7.4), collecting 6 ml 
per tube. The eluted fractions containing PICP were ana- 
lyzed by SDS-PAGE. The material from the S-200 gel 
chromatography containing PICP was dialyzed against 7 
M urea, 10 mM Tris, 10 mM acetic acid (pH 5.0), and then 
applied to a CM-cellulose column (1.5 X 20 cm) which 
was equilibrated with same buffer. The column was eluted 
with 5 bed volumes of the starting buffer and then with a 
400-ml linear gradient (0-0.2 M NaCI) in the above 
buffer. Eluates of the fractions were analyzed by SDS- 
PAGE. PICP containing the fraction from the CM-ion 
exchange chromatography was concentrated by ultrafiltra- 
tion (YM-10, Amicon, Japan) and then applied to a 
Sephacryl S-200 column (2.0 X 100 cm), which was equi- 
librated with 4 M urea, 0.15 M NaC1, and 50 mM Tris-HC1 
at pH 7.4. The elution was carried out with the same 
buffer, and 6 ml of eluate was collected per tube. The 
position of PICP was monitored by SDS-PAGE. The final 
purification of PICP was carried out by Agarose gel 
electrophoresis followed the method of Morgan et al. [ 11 ]. 
After electrophoretic separation, protein was recovered 
from the gel slices by melting at 70°C in 50 mM Tris, 1 
mM EDTA (pH 8) containing 1% SDS. The protein was 
concentrated by ultrafiltration (Diaflow membrane with a 
cut-off molecular weight of 3500). 
2.3. Metabolic labeling and autoradiography 
After cells were cultured with fresh serum-free medium 
for 4 h, they were incubated with serum-free medium 
containing 0.3 MBq of [3H]proline, leucine, or glu- 
cosamine for 15 h. After harvesting the medium, proteins 
in it were precipitated by the addition of trichloroacetic 
acid (TCA) and tannic acid (Wako Pure Chemical, Osaka) 
to final concentrations of 10% and 1%, respectively, after 
which they were kept at 4°C for 30 min. The precipitate 
was washed with 10% TCA and 1% tannic acid three 
times. Proteins were separated by SDS polyacrylamide g l 
electrophoresis (SDS-PAGE) under reduced conditions. 
Polyacrylamide slab gels were prepared by the Laemmli 
method [12]. The samples derived from the medium were 
loaded on 3% stacking gel and 12.5% separating el (pH 
8.8), respectively. Autoradiography was carried out by the 
method of Bonner and Lasky [13]. 
2.4. Antibody production 
New Zealand rabbits were purchased from a local sup- 
plier. Rabbits were initially injected with PICP extracted 
from Agarose in Freund's complete adjuvant (10 /xg of 
protein/rabbit). Booster injections in Freund's incomplete 
adjuvant were given every 1-3 weeks until a usable 
antibody titer was reached. Titers were assayed for reactiv- 
ity with PICP by enzyme-linked immunosorbent assay 
(ELISA) in microtiter wells coated with PICP (0.5 
/~g/well). 
2.5. lmmunoblotting 
The samples were separated by SDS-PAGE using 12.5% 
gel, and transferred onto nitrocellulose membranes for 1 h 
at 30 mA. The blue prestained molecular markers (GIBCO, 
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Fig. 1. Elution profile of the Concanavalin A (Con A) chromatography of the conditioned medium, and the SDS-PAGE pattern of the Con A-bound 
fraction. In the bound fraction, 70, 60, 55, 35 and 32 kDa proteins were recognized as major proteins. 
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BRL, Japan) were also transferred to the membranes for 
molecular weight calibration. The membranes were blocked 
by incubation for 30 min at room temperature in 20 mM 
Tris, 500 mM NaCI (pH 7.5) containing 3% albumin. 
Antibody against PICP was incubated overnight with the 
membrane in 20 mM Tris, 500 mM NaC1 (pH 7.5) contain- 
ing 1% albumin and 0.05% Tween 20. Following washing 
and incubation of the membrane with (1:1000), alkaline 
phosphatase conjugated Protein A, the membranes were 
developed with nitro-blue tetrazolium and 5-bromo-4- 
chloro-3-indolyl phosphate. 
2.6. Determination of the amino acid sequence 
The purified protein was cleaved with V8 protease by 
the method of Cleveland []4]. The peptide was transferred 
to PVDF membrane and determined the sequence as de- 
scribed previously [9]. 
added to each well. Cells were allowed to attach for 30 
min at 37°C, and cells not attached were removed by 
gentle washing by PBS. The number of cells was deter- 
mined by the modified MTT assay [16]. Osteonectin was 
purified from bone by the method of Fisher [17]. 
2.8. Bone formation induced by the implantation of dem- 
ineralized matrix containing bone morphogenetic protein 
(BMP) 
BMP was partially purified from bovine bone by chro- 
matographic method originally described by Urist [18]. 
BMP was reconstituted with demineralized bone matrix 
and implanted into the subcutaneous region of back of rats 
as described by Urist [18]. Bone was formed at the ectopic 
site at 2-3 weeks after implantation. Bone matrix proteins 
were solubilized by formic acid, and was applied to im- 
munoblotting. 
2.7. Cell attachment test 
Cell-attachment test was performed by the method of 
Sommarin [15]. Briefly, bovine serum albumin (BSA), 
fibronectin (FN), C-terminal propeptide of type I collagen 
(PICP) and osteonectin (ON) was coated at 10 /xg/ml in 
0.1 M NaHCO 3. In all cases, 100/xl of solution was added 
to each well of 96-well ELISA plates. After being coated 
overnight, the well was after-coated with 100 /zl of 1 
mg/ml of BSA in PBS for 2 h. A 100-pA of cell suspen- 
sion of osteoblastic MC3T3-E1 cells (1 × 10 4 cells) was 
3. Resul ts  
3.1. Purification of C-terminal propeptide of type I colla- 
gen (PICP) from conditioned medium of osteoblasts 
Pools of conditioned media (approx. 2 litres) were 
processed by Con A Sepharose chromatography. By these 
procedures, most glycoconjugates were selectively bound 
to the Con A column. In the bound fraction of the Con A 
chromatography, glycoconjugates with molecular weights 
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Fig. 2. Carboxymethyl cellulose column chromatography of the fractions containing PICP, and the SDS-PAGE pattern of its fractions. The materials 
containing PICP were dialyzed against 7 M urea/10 mM Tris/10 mM acetic acid (pH 5.0), and applied onto a CM-cellulose column which was 
equilibrated with same buffer. The column was eluted with a linear gradient of NaC1 (0-0.2 M). PICP was eluted at approx. 0.1 M NaCI. 
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Fig. 3. Sephacryl S-200 gel filtration chromatography of the fractions 
indicated by the bar in Fig. 2, and the SDS-PAGE pattern of the fractions. 
PICP was partially separated from the high molecular weight compo- 
nents. 
of 70 kDa, 60 kDa, 55 kDa, 35 kDa and 32 kDa were 
recognized as major proteins on SDS-PAGE (Fig. 1). The 
bound fraction was further separated by molecular sieve 
Sephacryl S-200 chromatography. Next, we processed the 
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Fig. 4. SDS-PAGE pattern of PICP under reduced condition extracted 
from Agarose after electrophoresis. 
Table 1 
The amino acid sequence of the protein purified from conditioned medium 
The purified protein D(A)-D-A-N-V-V(Q)-R-D-R-D(I)-L-E 
C-terminal propeptide D-D-A-N-V-V-R-D-R-D-L-E 
of type I collagen [26] 1 12 
The number indicates the position of amino acid from N-terminal end. 
PICP containing fraction by CM-cellulose ion-exchange 
chromatography. PICP was recognized in the bound frac- 
tion at an ionic strength of approx. 0.1 M NaC1 as revealed 
by SDS-PAGE of samples from each fraction (Fig. 2). 
This fraction also contained a component with a molecular 
weight of about 60 kDa. For further purification, the 
fractions from 46 to 50 in Fig. 2 were rechromatographed 
on a Sephacryl S-200 column to separate the higher molec- 
ular weight components. By the molecular sieve chro- 
matography, PICP was almost freed from the higher 
molecular weight components (Fig. 3). Final purification 
of PICP was carried out by Agarose gel electrophoresis, 
followed by extraction from the target gel band. By the 
extraction from Agarose gel, PICP was revealed to be a 
homogeneous form on SDS-PAGE (Fig. 4). 
3.2. Identification of PICP 
To identify the purified protein as PICP, amino acid 
sequence analysis was carried out. The sequence deter- 
mined was shown in Table 1. This sequence showed high 
homology with C-terminal propeptide of type I collagen. 
For further characterization, a molecular weight shift assay 
on SDS-PAGE under reduced or non-reduced condition 
was carried out. Under non-reduced conditions, the protein 
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Fig. 5. Autoradiography of serum-free conditioned medium derived from 
mature osteoblasts labeled by [3H]proline, leucine, or glucosamine. The 
molecular weight of 35 and 32 kDa proteins, which were PICP, were 
prominent secreted proteins in mature osteoblasts when they were labeled 
3 by [ H]radioactive r agents (indicated by arrow). 
M. Mizuno et al. / Biochimica et Biophysica Acta 1310 (1996) 97-102 101 
kDa 
43  ,~ 
30  "- 
18  ,- 
14  ,- 
5 .5  *- 
1 2 3 4 5 carried out. The antibody reacted with an approx. 37 kDa 
protein present in bone extract which was solubilized by 
formic acid from BMP-induced bone (Fig. 6). The molecu- 
lar weight of PICP in bone was slightly higher than that in 
conditioned medium. This discrepancy might be due to a 
difference of post-translational modification. 
3.5. Cell-attachment test 
PICP promoted cell attachment of osteoblastic MC3T3- 
E1 cells (Fig. 7). This effect was somewhat less efficient 
than that with fibronectin. On the other hand, osteonectin, 
which is a bone constituent, showed only weak affinity. 
C.B.B. staining Immunostaining 
Fig. 6. Immunostaining of bone matrix by anti-PICP antibody. This 
antibody specifically reacted with PICP, and the 37 kDa protein present 
in bone (indicated by arrow). Lane 1, prestained standard; lanes 2 and 4, 
Con A column bound fraction from conditioned medium; lanes 3 and 5, 
bone extract from BMP-induced bone. 
migrated as an approx. 100 kDa protein, and under re- 
duced conditions as 35 and 32 kDa proteins (data not 
shown). These findings proved that the purified protein 
was PICP. 
3.3. Identification of the osteoblastic origin of PICP 
To confirm that PICP was synthesized by mature os- 
teoblasts, autoradiography was carried out after metabolic 
labeling with [3H]proline, leucine, or glucosamine, and 
this procedure confirmed that PICP was a glycoprotein 
secreted by osteoblasts (Fig. 5). 
3.4. Presence of PICP in l~he bone 
To investigate whether PICP was present in bone, 
Western blotting analysis using anti-PICP antibody was 
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Fig. 7. Attachment, relative to BSA as 0 and FN as 1.0, of osteoblastic 
MC3T3-EI cells. BSA, bovine serum albumin; FN, fibronectin; PICP, 
C-terminal propeptide of type I collagen; ON, osteonectin. Data were 
evaluated from eight samples. 
4. Discussion 
In this study, we purified PICP from conditioned 
medium of osteoblastic MC3T3-E1 cells for the first time. 
We also found that PICP was present in bone, and was 
synthesized by osteoblasts. Using an anti-PICP antibody, 
PICP was recognized in BMP-induced bone. These find- 
ings indicated that PICP was stored in bone. 
N-terminal propeptide, which is another propeptide re- 
leased from type I procollagen, is present in bone [6]. This 
propeptide might play a role in the regulation of mineral- 
ization in bone [6]. In the current experiment, we found 
that PICP was present in bone. These findings indicate that 
N- and C-terminal propeptides are present in bone after 
they are released from procollagen. 
PICP is important for the collagenous helical formation 
[19]. In addition, PICP exhibits feedback regulation of 
procollagen synthesis [20,21]. The mechanism of this regu- 
lation is currently unclear, since findings that it acts both at 
the transcriptional level [20] and post-transcriptional level 
[21] are reported. Recently a pentapeptide in PICP was 
found to accelerate the extracellular matrix production in 
vitro [22]. These findings indicate that PICP regulates the 
phenotype expression of cells. 
In cartilage, C-terminal propeptide of type II collagen, 
referred to as chondrocalcin, has the capacity to bind 
hydroxyapatite, sphingomyelin [23] and anchorin C II [24], 
which are components of matrix vesicles, the putative 
initial site of mineral deposition. These findings imply that 
chondrocalcin plays a key role in calcification during 
endochondrial ossification. 
Recently, integrin a 2/31 was identified as a cell-surface 
receptor of PICP [25]. PICP can support he attachment 
and spreading of HTI080 fibrosarcoma cells. Thus we 
investigated whether PICP promotes the cell attachment of
osteoblastic MC3T3-El cells. Using our system, PICP 
accelerated this cell attachment. The degree of cell attach- 
ment by PICP was almost equal to that of fibronectin. 
Then, by Western blotting analysis, we investigated 
whether PICP was recognized in the cell-matrix fraction 
synthesized by osteoblastic MC3T3-E1 cells. PICP was 
102 M. Mizuno et al. / Biochimica et Biophysica Acta 1310 (1996) 97-102 
present in the cell-matrix fraction (data not shown). These 
findings indicate that PICP in bone may play a role in the 
maintenance of osteoblasts and osteocytes on bone matrix. 
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